EUROAPI

EUROAPI is one of the world’s largest manufacturers of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Established as an independent company in 2022 following its separation from Sanofi, EUROAPI is headquartered in Paris, France, and operates a global network of manufacturing facilities across Europe. The company specializes in developing, manufacturing, and supplying high-quality APIs, custom solutions, and contract development services for pharmaceutical companies worldwide.

EUROAPI offers one of the industry’s broadest API portfolios, covering small molecules, highly potent active ingredients (HPAPIs), prostaglandins, peptides, vitamin-based compounds, and complex chemical intermediates. Its advanced manufacturing technologies, process development expertise, and regulatory knowledge enable customers to accelerate product development while ensuring reliable commercial supply.

Serving customers in more than 80 countries, EUROAPI collaborates with innovative pharmaceutical companies, generic drug manufacturers, and biotechnology organizations across multiple therapeutic areas. The company places strong emphasis on sustainability, supply chain resilience, quality assurance, and environmental responsibility while continuously investing in modern manufacturing technologies and research capabilities. With decades of pharmaceutical manufacturing heritage inherited from Sanofi, EUROAPI has become a trusted global partner for pharmaceutical ingredient manufacturing and one of Europe’s leading API suppliers.